Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,616.85
(
0.08%
)
US TECH 100
24,206.80
(
2.83%
)
Dow Jones
46,584.46
(
-0.18%
)
Brent Oil
92.86
(
-8.26%
)
Bitcoin
71,350.16
(
-0.88%
)
News Focus
News Focus
Post# of 516945
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

nidan7500

Send PM Follow Ignore
Followers 58
Posts 10479
Boards Moderated 0
Alias Born 09/21/2016

nidan7500

Re: tschussmann1 post# 462758

Friday, 06/28/2024 1:06:31 PM

Friday, June 28, 2024 1:06:31 PM

Post# of 516945
tschuss...

This treatment will be submitted for approval and it will be approved in multiple locations in time. Ultimately, Blarcamesine will become a treatment of choice for multiple CNS issues...and Anavex will become a mega Pharma unless bought out. In the meantime still have some buy orders sitting in case the market chooses to fill them...

...I totally concur w/this thinking...thx

IMO, eventually we will see deeper work and study until CNAS diseases evolve as treatable for future populations.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News